Načítá se...
How Often Does Modern Neoadjuvant Chemotherapy (NAC) Downstage Patients to Breast-Conserving Surgery (BCS)?
BACKGROUND: NAC has been proven to increase BCS rates, but data are limited on conversion rates from BCS-ineligible (BCSi) to BCS-eligible (BCSe), specifically, in patients with large tumors. METHODS: Consecutive patients with stage I-III breast cancer treated with NAC from 11/2013–03/2019 were iden...
Uloženo v:
| Vydáno v: | Ann Surg Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7722183/ https://ncbi.nlm.nih.gov/pubmed/32514804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08593-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|